Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lifeward Ltd. - Ordinary Shares (NQ:LFWD)

8.040 -0.410 (-4.85%)
Streaming Delayed Price Updated: 9:45 AM EDT, Jul 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,394
Open 8.450
Bid (Size) 8.100 (200)
Ask (Size) 8.410 (100)
Prev. Close 8.450
Today's Range 8.000 - 8.820
52wk Range 4.140 - 10.98
Shares Outstanding 62,509,872
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
Initial $5.6 million provides immediate capital to accelerate commercialization of Lifeward's restorative healthcare platform; additional $5.6 million available upon achievement of defined commercial... 
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward (LFWD) Q4 2025 Earnings Transcript ↗
Lifeward (LFWD) Q4 2025 Earnings Transcript 
Via The Motley Fool
Topics World Trade

Performance

YTD
+7.5%
+7.5%
1 Month
+15.2%
+15.2%
3 Month
+22.2%
+22.2%
6 Month
+3.3%
+3.3%
1 Year
+1.1%
+1.1%

More News

Read More
News headline image
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Ltd (NASDAQ:LFWD) Q1 Revenue Misses Estimates as Strategic Transformation Takes Shape ↗
Via Chartmill
News headline image
Lifeward (LFWD) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Economy Intellectual Property World Trade
News headline image
Lifeward Reports First Quarter 2026 Financial Results
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Successfully Closes on Strategic Partnership with Oramed
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
From Lifeward Ltd.
Via GlobeNewswire
News headline image
LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years ↗
Via Stocktwits
News headline image
Lifeward Announces Reverse Share Split
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Appoints Bob Marshall as Chairman of the Board
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
From Lifeward Ltd.
Via GlobeNewswire
News headline image
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Ltd (NASDAQ:LFWD) Reports Mixed Q3 2025 Results ↗
Via Chartmill

Frequently Asked Questions

Is Lifeward Ltd. - Ordinary Shares publicly traded?
Yes, Lifeward Ltd. - Ordinary Shares is publicly traded.
What exchange does Lifeward Ltd. - Ordinary Shares trade on?
Lifeward Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Lifeward Ltd. - Ordinary Shares?
The ticker symbol for Lifeward Ltd. - Ordinary Shares is LFWD on the Nasdaq Stock Market
What is the current price of Lifeward Ltd. - Ordinary Shares?
The current price of Lifeward Ltd. - Ordinary Shares is 8.040
When was Lifeward Ltd. - Ordinary Shares last traded?
The last trade of Lifeward Ltd. - Ordinary Shares was at 07/08/26 09:45 AM ET
What is the market capitalization of Lifeward Ltd. - Ordinary Shares?
The market capitalization of Lifeward Ltd. - Ordinary Shares is 502.58M
How many shares of Lifeward Ltd. - Ordinary Shares are outstanding?
Lifeward Ltd. - Ordinary Shares has 503M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.